Message Board

Respected readers, authors and reviewers, you can add comments to this page on any questions about the contribution, review,        editing and publication of this journal. We will give you an answer as soon as possible. Thank you for your support!

Name
E-mail
Phone
Title
Content
Verification Code
x Close Forever Close
Volume 33 Issue 5
. 
Turn off MathJax
Article Contents
Article Navigation >  Journal of Pharmaceutical Practice and Service  > 2015  >  33(5): 453-456

YANG Xijing, ZHOU Fuping, ZHANG Qian, QIAN Qijun. One case of double primary tumors with secondary acute leukemia induced by chemotherapy drugs and literature review[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 453-456. doi: 10.3969/j.issn.1006-0111.2015.05.020
Citation: YANG Xijing, ZHOU Fuping, ZHANG Qian, QIAN Qijun. One case of double primary tumors with secondary acute leukemia induced by chemotherapy drugs and literature review[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 453-456. doi: 10.3969/j.issn.1006-0111.2015.05.020
shu

One case of double primary tumors with secondary acute leukemia induced by chemotherapy drugs and literature review

doi: 10.3969/j.issn.1006-0111.2015.05.020

  • Department of Biotherapy, Eastern Hepatobiliary Surgical Hospital, Shanghai 200438, China

  • Received Date: 2015-01-12
  • Rev Recd Date: 2015-04-28
  • In recent years, with a large number of chemotherapy development, the incidence of secondary leukemia increased year by year,an acute myelomonocytic leukemia after chemotherapy and radiotherapy in 1 case of ovarian cancer and breast cancer was reported. The time from first chemotherapy to acute leukemia onset was 37 months. This patient had rapid onset and short survival period. Reports in the literature suggested that alkylating agents, topoisomerase I inhibitors, platinum were all easy to induce secondary leukemia. Hematopoietic stem cell transplantation coud reduce mortality and prolong progression free survival.
  • [1] Smit CG, Meyler L.Acute myeloid leukaemia after treatment with cytostatic agents[J]. Lancet, 1970, 2(7674):671-672.
    [2] Leone G,Voso MT,Sica S, et al, Therapy related leukemias: susceptibility, prevention and treatment[J]. Leuk Lymphoma, 2001,41 (3-4): 255-276.
    [3] 肖志坚,都玉书.继发性白血病的研究现况[J].中华血液学杂志,2001,22(11):613-616.
    [4] Markman M. Chronic myelocytic leukemia as a secondary malignant condition in a patient receiving prolonged chemotherapy for ovarian carcinoma[J]. West J Med,1985,143 (2): 243.
    [5] Atichartakarn V, Punyammalee B, Nitiyanant P. Therapy related acute non-lymphocytic leukemia: report of 4 cases[J].Southeast Asian J Trop Med Public Health,1985, 16(3):421-430.
    [6] 夏忠军.卵巢癌化疗的继发性白血病[J].国际内科学杂志,1991,2(3):22-24.
    [7] Chambers SK, Chopyk RL, Chambers JT, et al, Development of leukemia after doxorubicin and cisplatin treatment for ovarian cancer[J]. Cancer, 1989,64 (12): 2459-2461.
    [8] Yokoyama Y, Futagami M, Fukushi Y, et al, Secondary acute nonlymphocytic leukemia following successful chemotherapy combining cisplatin, doxorubicin and cyclophosphamide for stage IV epithelial ovarian cancer[J]. Arch Gynecol Obstet,2000,263 (4): 206-207.
    [9] Travis LB, Holowaty EJ, Bergfeldt K, et al, Risk of leukemia after platinum-based chemotherapy for ovarian cancer[J]. N Engl J Med, 1999,340 (5): 351-357.
    [10] Yeasmin S, Nakayama K, Ishibashi M, et al, Therapy-related myelodysplasia and acute myeloid leukemia following paclitaxel-and carboplatin-based chemotherapy in an ovarian cancer patient: a case report and literature review[J]. Int J Gynecol Cancer, 2008,18 (6): 1371-1376.
    [11] Ishikawa M, Nakayama K, Rahman MT, et al, Therapy-related myelodysplastic syndrome and acute myeloid leukemia following chemotherapy (paclitaxel and carboplatin) and radiation therapy in ovarian cancer: a case report[J]. Eur J Gynaecol Oncol,2014,35 (4): 443-448.
    [12] Vay A, Kumar S, Seward S, et al, Therapy-related myeloid leukemia after treatment for epithelial ovarian carcinoma: an epidemiological analysis[J]. Gynecol Oncol,2011,123 (3): 456-460.
  • 加载中
通讯作者: 陈斌, bchen63@163.com
  • 1. 

    沈阳化工大学材料科学与工程学院 沈阳 110142

  1. 本站搜索
  2. 百度学术搜索
  3. 万方数据库搜索
  4. CNKI搜索
Get Citation
PDF
XML

Article Metrics

Article views(3406) PDF downloads(461) Cited by()

Related
Proportional views

One case of double primary tumors with secondary acute leukemia induced by chemotherapy drugs and literature review

doi: 10.3969/j.issn.1006-0111.2015.05.020
  • Department of Biotherapy, Eastern Hepatobiliary Surgical Hospital, Shanghai 200438, China
  • Received Date: 2015-01-12
  • Rev Recd Date: 2015-04-28

Abstract: In recent years, with a large number of chemotherapy development, the incidence of secondary leukemia increased year by year,an acute myelomonocytic leukemia after chemotherapy and radiotherapy in 1 case of ovarian cancer and breast cancer was reported. The time from first chemotherapy to acute leukemia onset was 37 months. This patient had rapid onset and short survival period. Reports in the literature suggested that alkylating agents, topoisomerase I inhibitors, platinum were all easy to induce secondary leukemia. Hematopoietic stem cell transplantation coud reduce mortality and prolong progression free survival.

YANG Xijing, ZHOU Fuping, ZHANG Qian, QIAN Qijun. One case of double primary tumors with secondary acute leukemia induced by chemotherapy drugs and literature review[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 453-456. doi: 10.3969/j.issn.1006-0111.2015.05.020
Citation: YANG Xijing, ZHOU Fuping, ZHANG Qian, QIAN Qijun. One case of double primary tumors with secondary acute leukemia induced by chemotherapy drugs and literature review[J]. Journal of Pharmaceutical Practice and Service, 2015, 33(5): 453-456. doi: 10.3969/j.issn.1006-0111.2015.05.020
shu

    HTML

Reference (12)

Catalog

    版权所有：《药学实践与服务》编辑委员会

    Supervisor & Sponsors: Address: No 325 Guohe Road, ShanghaiPost Code: 200433

    Tel: （021）81871324,81871397 E-mail: yxsjzzs@163.com

    网站备案号 沪ICP备05003363号-1

    Supported by: Beijing Renhe Information Technology Co., Ltd.  

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return